Atripla

Type: Product

Name: Atripla

First reported 21 hours ago - Updated 21 hours ago - 1 reports

Stalled Progress in the Fight Against HIV?

Has a stalemate been reached in the fight against HIV? After years of significant progress, a recent development could give the impression that progress might be stalled.In late April, the largest active study of an HIV vaccine was halted by the National ... [Published Motley Fool Discussion Boards - 21 hours ago]

Entities: HIV/AIDS, Gilead Sciences Inc, Vaccine, Drugs

First reported May 24 2013 - Updated May 24 2013 - 1 reports

United Nations

AFRICA: UN: AIDS Deaths Down, Treatment Up in Africa

) Aids Weekly PlusA new report released on May 21 by the Joint United Nations Program on HIV/AIDS demonstrated that the number of individuals in Africa who receive antiretroviral drugs increased from less than 1 million in 2005 to more than 7 million ... [Published AEGIS - May 24 2013]

Entities: HIV/AIDS, United Nations, LGBT, Complera, Atripla

First reported May 15 2013 - Updated May 15 2013 - 2 reports

NORTH CAROLINA: Possible Exposure to Hepatitis A

Jackson County, N.C., and state health officials are working together with the High Hampton Inn restaurant in Cashiers, N.C., to investigate a reported isolated case of hepatitis A in a restaurant employee. The restaurant has been proactive in contacting ... [Published AEGIS - May 15 2013]

Entities: HIV/AIDS, Hepatitis A, Exposure

First reported May 14 2013 - Updated May 14 2013 - 2 reports

Should You Buy Stock in Gilead After the Earnings Miss?

Keep track of the stocks that matter to you.Help yourself with the Fool's FREE and easy new watchlist service today. Time of transitionExamination of Gilead's sales numbers shows why earnings weren't at expected levels. Two of the company's top-selling ... [Published Motley Fool - May 14 2013]

Entities: Gilead Sciences Inc, Truvada, Atripla, Drugs, Stribild

First reported May 14 2013 - Updated May 14 2013 - 1 reports

Emtricitabine

ATRIPLA (Efavirenz, Emtricitabine, And Tenofovir Disoproxil Fumarate) Tablet, Film Coated [Physicians Total Care, Inc.]

Updated Date: May 6, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - May 14 2013]

Entities: Efavirenz, Atripla, Emtricitabine

First reported May 09 2013 - Updated May 09 2013 - 1 reports

UZBEKISTAN: Uzbeks Required to Produce STD, Drugs Certificates to Travel Abroad

According to Shuhrat Berdiyev, head of the Tashkent STD health clinic, Uzbekistan citizens wishing to travel outside of the country soon will have to produce certificates at border control stations demonstrating they suffer from neither drug addiction ... [Published AEGIS - May 09 2013]

Entities: HIV/AIDS, Uzbekistan, Drugs, LGBT

First reported May 07 2013 - Updated May 07 2013 - 1 reports

Italy HIV market: Latest market analysis presented

- GlobalData has released its new Country report, "". Human Immunodeficiency Virus (HIV), the causative agent of AIDS, has claimed millions of lives since its emergence. However, the advent of antiretroviral therapy (ART) has transformed the face of HIV/AIDS ... [Published TransWorldNews - May 07 2013]

Entities: HIV/AIDS, Italy, market analysis, Drugs

First reported May 05 2013 - Updated May 05 2013 - 1 reports

Atripla Label Adds Drug Interactions with Hepatitis C Protease Inhibitors Boceprevir and Telaprevir

Category: HIV TreatmentWritten by FDAThe U.S. Food and Drug Administration (FDA) announced this week that the product label information for Atripla -- the HIV single-tablet regimen containing efavirenz/tenofovir/emtricitabine -- has been updated to include ... [Published HIV and Hepatitis.com - May 05 2013]

Entities: Boceprevir, Telaprevir, Atripla

First reported May 03 2013 - Updated May 04 2013 - 2 reports

CALIFORNIA: Castro Businesses Offer Discounts to Men Who Get HIV Tests

On May 1, San Francisco’s Department of Public Health launched a 6-month program called, “Get a Test, Get a Discount.” The program encourages gay men to get tested for HIV and STDs on a regular basis by offering them coupons to local Castro District businesses, ... [Published AEGIS - May 04 2013]

Entities: HIV/AIDS, Discount, LGBT, Complera, Atripla

First reported May 02 2013 - Updated May 03 2013 - 6 reports

Don't Worry for a Second About Gilead's Earnings Miss

By the numbersFirst quarter non-GAAP earnings came in at $801.9 million, or $0.48 per diluted share. That's up from $704.4 million, or $0.45 per diluted share, during the first quarter of last year. However, the average analysts' estimate called for earnings ... [Published Motley Fool - May 03 2013]

Entities: Gilead Sciences Inc, Drugs, Stribild, Complera, Vertex Pharmaceuticals Inc

First reported Apr 26 2013 - Updated Apr 26 2013 - 1 reports

Atripla Label Adds Interactions with Hepatitis C Drugs Boceprevir and Telaprevir

Written by FDAThe U.S. Food and Drug Administration (FDA) announced this week that the product label information for Atripla -- the HIV single-tablet regimen containing efavirenz/tenofovir/emtricitabine -- has been updated to include information about ... [Published HIV and Hepatitis.com - Apr 26 2013]

Entities: Boceprevir, Telaprevir, Atripla

First reported Apr 19 2013 - Updated Apr 19 2013 - 1 reports

Changes to label for Atripla (efavirenz/emtricitabine/tenofovir disoproxil fumarate) tablets

FDA recently approved changes to the Atripla (efavirenz/emtricitabine/tenofovir disoproxil fumarate) tablet label to include the following changes:Lists Stribild as one of the drugs that should not be coadministered with AtriplaAdds drug interaction information ... [Published AEGIS - Apr 19 2013]

Entities: Emtricitabine, Tenofovir, Atripla

Quotes

Royalty said Thursday that Elan had "failed to maintain an appropriate balance between supporting management's acquisition plan and their fiduciary responsibilities to Elan shareholders."

Elan Rejects Latest Royalty Pharma Approach [Published 4 Traders - May 23 2013]

"We believe that the increased offer provides Elan Shareholders an attractive financial alternative that will allow them to realize value for their Elan stock in cash immediately."

Royalty Pharma Lowers Acceptance Threshold For Elan Offer [Published 4 Traders - May 23 2013]

...Spokesman Lt. Cmdr. Rob Lyon said the Navy had recently completed a review to ensure affected sailors "will have the greatest opportunity to be successful, and any concerns by their receiving commands will be addressed."

Policy change has yet to affect HIV-positive sailors [Published AEGIS - May 22 2013]

...efavirenz, emtricitabine and tenofovir Disoproxil fumarate tablets, 600 mg/200 mg/300 mgAgency Reviews Patent Application Approval Request for "Methods for Treatment of HIV and Other Infections Using a T Cell Or Viral Activator and Anti-Retroviral Combination Therapy" New Superiority Trial Showed LIVALO® pitavastatin 4 mg Provided Significantly Greater LDL-C Reduction in HIV-Infected Adults with Dyslipidemia versus...

Tentative approval of lamivudine and tenofovir disoproxil fumarate Tablets, 300 mg/300 mg [Published AEGIS - May 22 2013]

More Content

sort by: Date \| Relevance
Stalled Progress in the Fight Against HIV? [Published Motley Fool Discussion Boards - 21 hours ago]
Royalty Pharma Discloses Acceptance Levels of O... [Published Street Insider - May 24 2013]
Offer Update [Published TrustNet - May 24 2013]
AFRICA: UN: AIDS Deaths Down, Treatment Up in A... [Published AEGIS - May 24 2013]
Elan Rejects Latest Royalty Pharma Approach [Published 4 Traders - May 23 2013]
Royalty Pharma Lowers Acceptance Threshold For ... [Published 4 Traders - May 23 2013]
SOUTH CAROLINA: DHEC Orders North Charleston Cl... [Published AEGIS - May 23 2013]
CANADA: New Facility Unveiled for Homeless With... [Published AEGIS - May 23 2013]
SWITZERLAND: Swiss TB Rate Below European Average [Published AEGIS - May 23 2013]
FLORIDA: Gospel of Health: Block Party Promotes... [Published AEGIS - May 23 2013]
Policy change has yet to affect HIV-positive sa... [Published AEGIS - May 22 2013]
Tentative approval of lamivudine and tenofovir ... [Published AEGIS - May 22 2013]
COLORADO: Boulder Groups Honor More Than 150 Lo... [Published AEGIS - May 22 2013]
COLORADO: Peer to Peer: Teens Work to Educate P... [Published AEGIS - May 22 2013]
PENNSYLVANIA: Area Residents Screened for Hepat... [Published AEGIS - May 22 2013]
JAMAICA: AIDS Awareness Workshop Organised for ... [Published AEGIS - May 22 2013]
CONNECTICUT: At Hartford Public High School, A ... [Published AEGIS - May 21 2013]
Royalty Pharma Raises Takeover Bid for Elan [Published 4 Traders - May 20 2013]
Royalty Pharma Increases Offer for Elan to $12.... [Published Scottrade - May 20 2013]
Royalty Pharma Increases Offer for Elan to $12.... [Published FinanzNachrichten.de - May 20 2013]
AUSTRALIA: HIV Rates Triple in the Northern Ter... [Published AEGIS - May 19 2013]
ARIZONA: Routine Skin Testing Available Again a... [Published AEGIS - May 19 2013]
ARIZONA: Parsons Foundation Gives $3 Million to... [Published AEGIS - May 19 2013]
CALIFORNIA: Donation to Fund HPV Vaccines for Y... [Published AEGIS - May 17 2013]
WASHINGTON: Front Porch -- Share Your Experienc... [Published AEGIS - May 17 2013]
NEW JERSEY: Drug Company Donates Thousands to H... [Published AEGIS - May 17 2013]
CALIFORNIA: Oakland HIV/AIDS Housing the Focus ... [Published AEGIS - May 16 2013]
Genesee County Health Department Seeks Help at ... [Published AEGIS - May 16 2013]
CALIFORNIA: NorCal AIDS Cycle Opening and Closi... [Published AEGIS - May 16 2013]
NORTH CAROLINA: Possible Exposure to Hepatitis A [Published AEGIS - May 15 2013]

sort by: Date \| Relevance
Bristol-Myers Squibb Receives US FDA sNDA Appro... [Published Business Wire - May 03 2013]
AHF Says Corporate Welfare Fuels Gilead’s Recor... [Published Business Wire - May 02 2013]
Research and Markets: Atripla (HIV) - Forecast ... [Published Business Wire Health News - Apr 24 2013]
Atripla (HIV) - Forecast and Market Analysis to... [Published PR Newswire: Health - Apr 16 2013]